Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
3.200
+0.080 (2.56%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Lisata Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 29 | 16 | 25 | 22 | 20 | 50 | |
| Market Cap Growth | 71.08% | -34.42% | 12.58% | 11.75% | -60.48% | 81.39% | |
| Enterprise Value | 13 | -3 | -11 | -32 | -55 | -50 | |
| Last Close Price | 3.20 | 1.86 | 2.98 | 2.73 | 2.53 | 12.62 | |
| PS Ratio | 170.02 | 96.51 | 25.02 | - | - | - | |
| PB Ratio | 1.90 | 1.12 | 0.85 | 0.46 | 0.30 | 0.55 | |
| P/TBV Ratio | 1.95 | 1.10 | 0.85 | 0.46 | 0.30 | 0.55 | |
| Debt / Equity Ratio | - | - | 0.01 | 0.01 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -1.09 | -1.09 | -1.06 | -1.05 | -1.04 | -1.02 | |
| Net Debt / EBITDA Ratio | 0.88 | 0.88 | 1.40 | 1.97 | 2.53 | 3.25 | |
| Net Debt / FCF Ratio | 1.00 | 1.00 | 1.61 | 2.51 | 3.20 | 4.23 | |
| Asset Turnover | 0.01 | 0.01 | 0.02 | - | - | - | |
| Quick Ratio | 5.42 | 5.42 | 5.83 | 7.67 | 10.96 | 21.00 | |
| Current Ratio | 5.77 | 5.77 | 6.16 | 8.18 | 11.26 | 21.27 | |
| Return on Equity (ROE) | -75.53% | -75.53% | -51.77% | -36.49% | -68.50% | -44.21% | |
| Return on Assets (ROA) | -43.15% | -43.15% | -31.23% | -25.16% | -20.00% | -27.30% | |
| Return on Capital Employed (ROCE) | -124.10% | -124.10% | -76.20% | -53.40% | -40.80% | -31.40% | |
| Earnings Yield | -57.38% | -101.09% | -79.89% | -93.79% | -272.69% | -54.59% | |
| FCF Yield | -55.28% | -97.38% | -77.37% | -90.15% | -107.90% | -44.33% | |
| Buyback Yield / Dilution | -4.30% | -4.30% | -3.17% | -55.85% | -40.46% | -258.29% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.